Withdrawal of support for the active substance TMAD from the BPR Review Program

The following active substance/product-type combination is no longer considered to be supported in the Biocidal Products Regulation (BPR) Review Program:

  • Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5 (1H,3H)-dione (TMAD) Product type 2 (disinfectants and algaecides not intended for direct application to humans or animals)

Yorda’s Hive, 6 June 2018 ; Posted in Uncategorized